Akums Drugs & Pharmaceuticals will hold a board meeting on February 13, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. This meeting is a standard procedure for the company to review its financial performance. Investors are awaiting the results to assess the company’s performance.
Board Meeting Announcement
Akums Drugs and Pharmaceuticals Limited has scheduled a meeting of its Board of Directors to be held on Friday, February 13, 2026. The primary agenda is to review and approve the company’s financial performance.
Financial Results on the Agenda
The board will specifically consider and approve the unaudited (Standalone & Consolidated) Financial Results for the quarter and nine months that concluded on December 31, 2025. Investors and stakeholders are expecting these results to gauge the company’s performance.
Source: BSE
